Skip to content

S. 127 · 118th Congress (2023–2025)

Pharmacy Benefit Manager Transparency Act of 2023

This bill generally prohibits pharmacy benefit managers (PBMs) from engaging in certain practices when managing the prescription drug benefits under a health insurance plan, including charging the plan a different amount than the PBM reimburses the pharmacy.

The bill also prohibits PBMs from arbitrarily, unfairly, or deceptively (1) clawing back reimbursement payments, or (2) increasing fees or lowering reimbursements to pharmacies to offset changes to federally funded health plans.

PBMs are not subject to these prohibitions if they (1) pass along 100% of any price concession or discount to the health plan, and (2) disclose specified costs, prices, reimbursements, fees, markups, discounts, and aggregate payments received with respect to their PBM services.

Further, PBMs must report annually to the Federal Trade Commission (FTC) certain information about payments received from health plans and fees charged to pharmacies.

The FTC and state attorneys general are authorized to enforce the provisions of the bill.

Show official title

A bill to prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes.

Expired in Senate committee

Derived from the legislative history, not an official disposition.

Latest actionReported by committee

This bill’s path

This is S. 127’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed Senate

  3. Passed House

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Sen. Maria Cantwell (D-WA)
Cosponsors
14 cosponsors

7 original · 7 later

10 R · 4 D

  1. Sen. Mike Braun (R-IN)· Original · Jan 26, 2023
  2. Sen. Shelley Moore Capito (R-WV)· Original · Jan 26, 2023
  3. Sen. Chuck Grassley (R-IA)· Original · Jan 26, 2023
  4. Sen. Cindy Hyde-Smith (R-MS)· Original · Jan 26, 2023
  5. Sen. Jerry Moran (R-KS)· Original · Jan 26, 2023
  6. Sen. Jon Tester (D-MT)· Original · Jan 26, 2023
  7. Sen. Thom Tillis (R-NC)· Original · Jan 26, 2023
  8. Sen. John Boozman (R-AR)· Later · Jan 31, 2023
  9. Sen. Peter Welch (D-VT)· Later · Mar 6, 2023
  10. Sen. Roger Marshall (R-KS)· Later · Mar 30, 2023
  11. Sen. Martin Heinrich (D-NM)· Later · May 2, 2023
  12. Sen. Joni Ernst (R-IA)· Later · May 4, 2023
  13. Sen. Mike Rounds (R-SD)· Later · Jul 19, 2023
  14. Sen. Jeanne Shaheen (D-NH)· Later · Nov 9, 2023
Policy area
Health
Subjects
  • Civil actions and liability
  • Congressional oversight
  • Government information and archives
  • Government studies and investigations
  • Health care costs and insurance
  • Medical ethics
  • Prescription drugs
  • State and local government operations

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in Senate

    Document: Introduced in Senate

    Sources
  2. Latest
    ▸ 3 committee actions · Jan 26, 2023 – Dec 13, 2023
    1. Referred to committee

      Read twice and referred to the Committee on Commerce, Science, and Transportation.

      Sources
    2. Ordered reported

      Committee on Commerce, Science, and Transportation. Ordered to be reported with an amendment in the nature of a substitute favorably.

      Sources
    3. Reported by committee

      Committee on Commerce, Science, and Transportation. Reported by Senator Cantwell with an amendment in the nature of a substitute. Without written report.

      Sources
  3. Expired

    Introduced → Reported by committee → No further action before the 118th Congress ended.

Committees

  1. SenateCommerce, Science, and TransportationReferred Jan 26, 2023 · Markup Mar 22, 2023 · Reported Dec 13, 2023
    1. Mar 22, 2023 · Meeting

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in Senate
Reported to Senate
Titles (2)
  1. Pharmacy Benefit Manager Transparency Act of 2023

    Display title, Short title · Introduced in Senate, Reported to Senate

  2. A bill to prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes.

    Official title · Introduced in Senate